ETHZ
NASDAQ
ETHZilla Corporation - Common Stock
Healthcare
· Biotechnology
$2.75
▼ $-0.06
(-2.14%)
Vol 384K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$93.2M
ROE
-192.6%
D/E
111.60
Beta
2.53
52W
$5–$75
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -141.3% | — | -141.3% | -141.3% | -141.3% | -192.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 26.25 | — | 26.25 | 26.25 | 26.25 | 111.60 |
| Current Ratio | 0.58 | — | 0.58 | 0.58 | 0.58 | 10.07 |
Key Ratios
ROA (TTM)
-86.2%
EPS (TTM)
$-65.26
52W High
$74.50
52W Low
$5.02
$5.02
52-Week Range
$74.50
How does ETHZ compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ETHZ valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ETHZ profitability vs Biotechnology peers
ROE
-192.6%
▼
186%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-86.2%
▼
85%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ETHZ financial health vs Biotechnology peers
D/E ratio
111.6
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
10.1
▲
127%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.5
▲
161%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ETHZ fundamentals radar
ETHZ
Peer median
Industry
ETHZ profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ETHZ vs peers: key metrics
Latest News
No related news yet